This reference page provides a technical overview of specific probiotic strains investigated for their roles in the oral microbiome. It categorizes strains by their primary research focus, including dental caries, periodontal health, and halitosis, based on clinical trials and microbiological studies.
Overview of Oral Probiotics
Oral probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host's oral cavity. Unlike gut-focused probiotics, these strains are typically selected for their ability to adhere to oral mucosa and teeth, produce antimicrobial substances (such as bacteriocins), and compete with pathogenic bacteria like Streptococcus mutans and Porphyromonas gingivalis.
Glossary of Studied Strains
- Streptococcus salivarius K12 (BLIS K12)
- A primary colonizer of the human oral cavity. Research focuses on its ability to produce bacteriocin-like inhibitory substances (BLIS) that target Streptococcus pyogenes. Studies indicate a reduction in the recurrence of streptococcal pharyngitis and tonsillitis (Di Pierro et al., 2012). It is also studied for its role in reducing volatile sulfur compounds (VSCs) associated with halitosis (Burton et al., 2006).
- Streptococcus salivarius M18 (BLIS M18)
- This strain produces enzymes (dextranase and urease) that help neutralize salivary pH and break down dental plaque. Clinical trials have observed a reduction in plaque scores and a decrease in the Cariogram risk profile in children (Burton et al., 2013).
- Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289)
- Often studied in combination (commercially known as Prodentis), these strains are researched for their anti-inflammatory effects in the gingival tissues. Meta-analyses of clinical trials show a significant reduction in gingival bleeding and pocket depth in patients with periodontitis (Martin-Cabezas et al., 2016).
- Lactobacillus rhamnosus GG
- While primarily known for gut health, this strain is studied in dentistry for its ability to inhibit the growth of Streptococcus mutans. Long-term studies in children have shown a correlation between consumption and a lower risk of dental caries (Nase et al., 2001).
- Lactobacillus paracasei GMNL-33
- This strain is investigated for its high adherence to oral epithelial cells and its inhibitory effect against S. mutans. Research suggests it may reduce the levels of decay-causing bacteria in saliva when used consistently (Chuang et al., 2011).
- Lactobacillus brevis CD2
- Studied for its high levels of arginine deiminase, which can inhibit the production of inflammatory cytokines. Research has focused on its application for managing oral ulcers and gingival inflammation (Riccia et al., 2007).
- Bifidobacterium animalis subsp. lactis (BB-12)
- Clinical research indicates that this strain may reduce the plaque index and the levels of S. mutans in the oral cavity, particularly when delivered via dairy products or lozenges (Caglar et al., 2008).
- Lactobacillus plantarum (specifically L-137)
- Heat-killed versions of this strain (postbiotics) have been studied for their ability to improve periodontal pocket depth and immune response in the oral cavity (Iwasaki et al., 2016).
- Lactobacillus sakei
- Emerging research explores this strain's role in the sinus microbiome and its potential to inhibit Corynebacterium tuberculostearicum, a pathogen associated with chronic rhinosinusitis (Abreu et al., 2012).
Comparative Research Summary
| Strain Name | Primary Research Area | Observed Mechanism | Key Study Outcome |
|---|---|---|---|
| S. salivarius K12 | Halitosis / Throat Health | BLIS production (Salivaricin A2, B) | ~85% reduction in VSCs in some subjects (Source) |
| S. salivarius M18 | Dental Caries | Dextranase & Urease production | Significant reduction in plaque scores (Source) |
| L. reuteri (DSM 17938) | Periodontal Disease | Reuterin production / Anti-inflammatory | Reduction in Bleeding on Probing (BOP) (Source) |
| L. rhamnosus GG | Pediatric Caries | Pathogen competition | Lower incidence of dental decay in children (Source) |
| L. brevis CD2 | Gingival Inflammation | Arginine deiminase activity | Reduction in metalloproteinase activity (Source) |
| B. lactis BB-12 | Plaque Control | Biofilm interference | Reduction in salivary S. mutans counts (Source) |
| L. paracasei GMNL-33 | Caries Prevention | High oral mucosal adherence | Inhibition of S. mutans colonization (Source) |
| L. plantarum L-137 | Periodontal Health | Immune modulation (IL-12 production) | Improvement in probing pocket depth (PPD) (Source) |
| L. sakei | Sinus/Upper Respiratory | Competitive exclusion | Protection against sinus pathogenic overgrowth (Source) |
Last verified: 2026-07-02
Sources
- Di Pierro et al. (2012). Clinical evaluation of Streptococcus salivarius K12 in the prevention of recurrent pharyngitis.
- Burton et al. (2006). Effect of Probiotic Streptococcus salivarius K12 on Oral Malodor Parameters.
- Burton et al. (2013). Influence of the probiotic Streptococcus salivarius M18 on dental caries in children.
- Martin-Cabezas et al. (2016). Clinical efficacy of probiotics as an adjunctive therapy to scaling and root planing.
- Nase et al. (2001). Effect of Long-Term Consumption of a Probiotic Bacterium, Lactobacillus rhamnosus GG, in Milk on Dental Caries and Caries Risk in Children.
- Chuang et al. (2011). Effect of probiotic Lactobacillus paracasei on Streptococcus mutans in children.
- Riccia et al. (2007). Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease.
- Caglar et al. (2008). Short-term effect of ice-cream containing Bifidobacterium lactis Bb-12 on salivary Streptococcus mutans.
- Iwasaki et al. (2016). Daily intake of heat-killed Lactobacillus plantarum L-137 improves periodontal status.
- Abreu et al. (2012). Sinus Microbiome Diversity Depletion and Corynebacterium tuberculostearicum Enrichment Mediates Rhinosinusitis.